Loading
ET
Echo Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SCHOENBART ALAN WAYNE, was filed 20 May 2015.
Echo Therapeutics, Inc.: what insiders have been doing
Echo Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Echo Therapeutics, Inc. in twelve months, the latest record being from 23 March 2017.
Since 2006, the database holds 22 purchases and no sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
96
Thresholds
n/a
Buy Volume
€535,567
22 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2015FY ended December 2015 · cache
Income statement
Net income-19.8M
Last declaration on 23 March 2017
Declarations96 total
25,000 shares0Common Stock, par value $.01SEC:0001415889-17-000476:0
25,000 shares0Comon Stock, par value $.01SEC:0001415889-17-000478:0
28,000 shares@ US$0.34100.0% of flowCommon Stock, par value $.01SEC:0001415889-17-000471:0
100,000 shares0Common Stock, par value $.01SEC:0001415889-17-000472:0
100,000 shares0Common StockSEC:0001415889-16-007497:0
150,000 shares0Common StockSEC:0001415889-16-004940:0
100,000 shares0Common StockSEC:0001415889-16-004934:0
8,000 shares@ US$1.48Common StockSEC:0001415889-15-001832:0
Canonical exit: 18 Aug 2015 (T+90)
2,500 shares@ US$1.44Common StockSEC:0001415889-15-001834:0
Canonical exit: 18 Aug 2015 (T+90)
447,590 sharesCommon StockSEC:0001140361-15-020797:1
1,052,410 sharesCommon StockSEC:0001140361-15-020797:0
7,250 shares0Common StockSEC:0001415889-14-002133:0
10,656 shares@ US$2.20Common StockSEC:0001140361-14-027289:0
Canonical exit: 25 Sept 2014 (T+90)
55,083 shares@ US$2.20Common StockSEC:0001140361-14-027289:1
Canonical exit: 28 Sept 2014 (T+90)
2,300 shares@ US$2.20Common StockSEC:0001140361-14-026909:0
Canonical exit: 23 Sept 2014 (T+90)
15,000 shares@ US$2.20Common StockSEC:0001140361-14-026909:1
Canonical exit: 24 Sept 2014 (T+90)
16,490 shares@ US$2.1996Common StockSEC:0001140361-14-026587:0
Canonical exit: 18 Sept 2014 (T+90)
85 shares@ US$2.20Common StockSEC:0001140361-14-026587:1
Canonical exit: 21 Sept 2014 (T+90)
386 shares@ US$2.20Common StockSEC:0001140361-14-026587:2
Canonical exit: 22 Sept 2014 (T+90)
14,500 shares0Comon StockSEC:0001415889-14-000823:0
14,500 shares0Common StockSEC:0001415889-14-000027:0
14,500 shares0Common StockSEC:0001415889-14-000029:0
14,500 shares0Common StockSEC:0001415889-14-000028:0
55,655 shares@ US$2.75Common StockSEC:0001140361-13-045902:0
Canonical exit: 10 Mar 2014 (T+90)
13,914 shares@ US$2.75Common StockSEC:0001140361-13-045902:1
Canonical exit: 10 Mar 2014 (T+90)
25 of 96 declarations
About Echo Therapeutics, Inc.
Echo Therapeutics, Inc. is a company focused on developing non-invasive glucose monitoring technologies. It is listed on the XNAS market.
